David D. Frisbie, DVM, PhD

Research Interests: Gene therapy, intra-articular therapeutics, new methods of cartilage repair. David D. Frisbie, DVM, PhD. Dr. Frisbie began his professional career after obtaining both a Bachelors Degree in Biochemistry and a Doctor of Veterinary Medicine (DVM) from the University of Wisconsin. He then went to New York, where he completed a Surgical Internship at Cornell University and began his research in joint disease. After completing his internship, Dr. Frisbie came to Colorado State University, where he continued his joint research, completed a Surgical Residency in Large Animal Surgery and obtained a Masters Degree in Joint Pathobiology. After completion of his residency, Dr. Frisbie began his work on a novel way to treat joint disease using gene therapy, which was the focus of his PhD. During work on his PhD. Dr. Frisbie became Board certified in Large Animal Surgery and is a Diplomate of the American College of Veterinary Surgeons. He joined the faculty as an Assistant Professor in 1999.

His current joint disease research is in two basic fields: 1) the evaluation of intra-articular therapeutics and their effects on joint disease (well known therapeutics he has evaluated include Legend, Adequan, Vetalog and Depo-Medrol); 2) new methods of cartilage repair. These methods include cutting edge technology aimed at arthroscopic repair of cartilage in the athletic horse. Dr. Frisbie is also exploring methods to augment fracture healing in both noninfected and infected cases using gene transfer.